14 Sep 2007 - Response Biomedical Corporation announced the appointment of S. Wayne Kay as Chief Executive Officer (CEO). Mr. Kay was also appointed to the Company's Board of Directors.
Mr. Kay is a former President, CEO and Director of Quidel Corporation, a company in the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point-of-care (POC) in infectious diseases and reproductive health. Since leaving Quidel in 2004, Mr. Kay served as an executive advisor to the management and boards of several early stage companies, mainly in the San Francisco and San Diego areas. He also served as an executive advisor to the blue-chip healthcare/life sciences venture capital funds Kleiner Perkins Caufield and Byers.
As part of Mr. Kay's compensation package, he has been granted options to acquire 1,500,000 common shares of the Company, subject to vesting requirements. The options are exercisable at a price of $1.07 per common share.
 |
www.bionity.com/news/e/69688 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/69688 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |